Ozop Surgical says Power Conversion Technologies shipped equipment to Fortune 500 defense firm

Ozop Surgical says Power Conversion Technologies shipped equipment to Fortune 500 defense firm

Proactive Investors

Published

Ozop Surgical Corp (OTCPK:OZSC) announced that Power Conversion Technologies Inc (PCTI) has shipped an order for equipment to one of its clients — a publicly traded Fortune 500 engineering, procurement, fabrication, construction and maintenance company.  The equipment will be used for the client’s research in naval nuclear propulsion technology which the company conducts in conjunction with the US Navy, according to a statement Tuesday.  Ozop Surgical said PCTI also received additional follow-on purchase orders expected to ship in the coming months.  READ: Ozop Surgical reports order news from Power Conversion Technologies as merger nears Ozop Surgical said PCTI, a private company it announced in February it was acquiring, has extensive experience in servicing naval technology-related clients and is working on several prospective bids in this area which it expects to receive responses on in the near future. Some of PCTI's clients include all branches of the US Department of Defense, including the US Army and the US Air Force, and NASA as well as other global military organizations. “Our global naval customers have trusted our equipment to provide power to in-hull submarine systems for more than 20 years to global naval organizations,” said PCTI President Catherine Chis.  “In the history of the company, this particular project was one of the most impressive, sophisticated projects we have had the opportunity to engineer and manufacture. It was an accomplishment for our entire team.” Ozop Surgical is a Florida-based company that manufactures endoscopic instruments, surgical implants and other devices focused on neurological issues and pain management. The company’s stock recently traded up 25% to $0.0064 a share in New York. Contact the author: patrick@proactiveinvestors.com Follow him on Twitter @PatrickMGraham

Full Article